Efficacy, Safety of T2769 in Dry Eye Disease

Efficacy and Safety Assessment of T2769 in Patients With Moderate to Severe Dry Eye Syndrome

Efficacy of T2769 in Dry Eye Desease

Multicenter and open study

Inclusion Criteria:

• Signed and dated informed consent
• Male or female aged from ≥ 18 years old
• Known Dry Eye Syndrome requiring artificial tears within the last 3 months prior to study screening

Exclusion Criteria:

• Best far corrected visual acuity ≤ 2/10
• Severe blepharitis Severe dry eye